Snap Fluidics is building a handheld medical device that can rapidly detect and quantify pathogen infection, such as SARS-CoV-2, at the point-of-care. Their proprietary microfluidic cartridge enables standard quantitative nucleic acid detection (qPCR) to be deployed in the field, rather than in a laboratory, decreasing results turnaround time from days to minutes.